Invention Grant
- Patent Title: Fluid component analysis system and method for glucose monitoring and control
-
Application No.: US13857949Application Date: 2013-04-05
-
Publication No.: US09302045B2Publication Date: 2016-04-05
- Inventor: Peter Rule
- Applicant: OPTISCAN BIOMEDICAL CORPORATION
- Applicant Address: US CA Hayward
- Assignee: OptiScan Biomedical Corporation
- Current Assignee: OptiScan Biomedical Corporation
- Current Assignee Address: US CA Hayward
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: A61B5/00
- IPC: A61B5/00 ; A61M31/00 ; A61M5/172 ; A61B5/155 ; A61B5/145 ; A61B5/1455 ; G06F19/00 ; A61M5/168 ; A61M5/14 ; A61M5/142

Abstract:
Disclosed are methods and apparatuses for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment dose (e.g. insulin, dextrose, etc.) and provide glycemic control. The dose of the treatment drug may be based on the patient's calculated sensitivity to treatment dosing, for example. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte. Delivery of the treatment drug can be cut off if the determined analyte concentration indicates that continued delivery would be harmful to the patient.
Public/Granted literature
- US20140066844A1 FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL Public/Granted day:2014-03-06
Information query